The current recommendation of Hold for HCA Healthcare Inc (NYSE:HCA) has been derived by using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking HCA has had from Portfolio Grader for 4 months.

The current recommendation of Hold for HCA Healthcare Inc (NYSE:HCA) is derived using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methods. HCA has maintained this ranking for 4 months.

HCA Healthcare Inc (NYSE:HCA) is ranked as a Hold using the approach of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

With a $26.9 billion market value, HCA Healthcare Inc (NYSE:HCA) ranks in the top quarter of its industry group, Health Care Providers & Services, and in the top decile of sector group, Health Care, in market value. From the vantage point of investment attractiveness, The current Portfolio Grader ranking for HCA puts it 52 among the 82 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 466 among the 781 companies in the sector, and number 2,982 in the nearly 5,000 company Portfolio Grader universe.

HCA Healthcare Inc (NYSE:HCA) is a $28.1 billion in market value constituent of the Health Care Providers & Services GICS industry group where The current Portfolio Grader ranking for HCA puts it 47 among the 82 companies in this industry group, which is a below-average position. HCA is ranked in the third quartile of the sector with a ranking of 391 among the 782 companies in the sector and number 2,533 in the 5000 company Portfolio Grader company universe.

HCA Healthcare Inc (NYSE:HCA) is ranked as a Hold using Louis Navellier's investing system and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

As one of the 783 companies in the GICS Health Care sector HCA Healthcare Inc (NYSE:HCA) is a member of the 82 company Health Care Providers & Services GICS industry group within this sector. HCA's market value is $27.8 billion which places it in the top quarter of its industry group. The ranking for HCA by Portfolio Grader places it 44 among the 82 companies in this industry group, which is a below-average position; in the top half of the sector with a ranking of 351 among the 783 companies in the sector, and number 2,420 in the nearly 5,000 company Portfolio Grader universe.

As one of the 782 companies in the GICS Health Care sector HCA Healthcare Inc (NYSE:HCA) is a member of the 82 company Health Care Providers & Services GICS industry group within this sector. HCA's market value is $29.4 billion which places it in the top quarter of its industry group. The ranking for HCA by Portfolio Grader places it 51 among the 82 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 417 among the 782 companies in the sector, and number 2,851 in the nearly 5,000 company Portfolio Grader universe.

HCA Healthcare Inc (NYSE:HCA) is a member of the 83 company Health Care Providers & Services GICS industry group, which is part of the 783 company GICS Health Care sector. The market value of HCA is $27.1 billion which falls in the top 25% of its industry group. The current Portfolio Grader ranking for HCA puts it 54 among the 83 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 481 among the 783 companies in the sector, and number 3,252 in the nearly 5,000 company Portfolio Grader universe.

The current recommendation of Hold for HCA Healthcare Inc (NYSE:HCA) is computed using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. HCA has maintained this ranking for 2 months.

The current recommendation of Hold for HCA Healthcare Inc (NYSE:HCA) is computed using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. HCA has maintained this ranking for 2 months.